Skip to main content

Hercules Capital Stock Forecast, Price & News

$17.18
+0.20 (+1.18 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.93
$17.30
50-Day Range
$15.98
$17.66
52-Week Range
$9.87
$17.72
Volume699,843 shs
Average Volume700,411 shs
Market Capitalization$1.99 billion
P/E Ratio15.91
Dividend Yield7.54%
Beta1.57
30 days | 90 days | 365 days | Advanced Chart
Receive HTGC News and Ratings via Email

Sign-up to receive the latest news and ratings for Hercules Capital and its competitors with MarketBeat's FREE daily newsletter.


Hercules Capital logo

About Hercules Capital

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
CUSIP42709650
Phone650-289-3060
Employees82
Year Founded2003

Sales & Book Value

Annual Sales$267.87 million
Cash Flow$1.67 per share
Book Value$10.83 per share

Profitability

Net Income$173.60 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap$1.99 billion
Next Earnings Date7/29/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.51 out of 5 stars

Finance Sector

636th out of 1,930 stocks

Investment Offices, Not Elsewhere Classified Industry

6th out of 172 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Hercules Capital (NYSE:HTGC) Frequently Asked Questions

Is Hercules Capital a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hercules Capital in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Hercules Capital stock.
View analyst ratings for Hercules Capital
or view top-rated stocks.

What stocks does MarketBeat like better than Hercules Capital?

Wall Street analysts have given Hercules Capital a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Hercules Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Hercules Capital's next earnings date?

Hercules Capital is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Hercules Capital
.

How were Hercules Capital's earnings last quarter?

Hercules Capital, Inc. (NYSE:HTGC) issued its quarterly earnings results on Thursday, April, 29th. The financial services provider reported $0.29 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.29. The financial services provider had revenue of $68.76 million for the quarter, compared to analysts' expectations of $67.68 million. Hercules Capital had a net margin of 42.72% and a trailing twelve-month return on equity of 13.58%.
View Hercules Capital's earnings history
.

How has Hercules Capital's stock been impacted by Coronavirus (COVID-19)?

Hercules Capital's stock was trading at $12.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HTGC stock has increased by 40.8% and is now trading at $17.18.
View which stocks have been most impacted by COVID-19
.

How often does Hercules Capital pay dividends? What is the dividend yield for Hercules Capital?

Hercules Capital declared a quarterly dividend on Tuesday, April 27th. Shareholders of record on Wednesday, May 12th will be given a dividend of $0.39 per share on Wednesday, May 19th. This represents a $1.56 annualized dividend and a dividend yield of 9.08%. The ex-dividend date of this dividend is Tuesday, May 11th. This is a positive change from Hercules Capital's previous quarterly dividend of $0.32.
View Hercules Capital's dividend history
.

Is Hercules Capital a good dividend stock?

Hercules Capital pays an annual dividend of $1.28 per share and currently has a dividend yield of 7.54%. HTGC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Hercules Capital does not yet have a strock track record of dividend growth. The dividend payout ratio of Hercules Capital is 90.78%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Hercules Capital will have a dividend payout ratio of 94.12% in the coming year. This indicates that Hercules Capital may not be able to sustain their current dividend.
View Hercules Capital's dividend history.

What price target have analysts set for HTGC?

7 analysts have issued 12-month price targets for Hercules Capital's shares. Their forecasts range from $12.75 to $18.50. On average, they expect Hercules Capital's share price to reach $15.36 in the next year. This suggests that the stock has a possible downside of 10.6%.
View analysts' price targets for Hercules Capital
or view top-rated stocks among Wall Street analysts.

Who are Hercules Capital's key executives?

Hercules Capital's management team includes the following people:
  • Mr. Scott Bluestein, CEO, Chief Investment Officer, Pres & Director (Age 43, Pay $3.33M) (LinkedIn Profile)
  • Mr. Seth Hardy Meyer, CFO & Chief Accounting Officer (Age 52, Pay $1.24M)
  • Ms. Melanie Grace, Chief Compliance Officer, Gen. Counsel & Corp. Sec. (Age 52, Pay $588.81k)
  • Mr. Roy Y. Liu, Managing Director (Age 60)
  • Mr. Steve Kuo, Sr. MD & Group Head of Technology (Age 46)
  • Mr. Michael W. Hara, Managing Director of Investor Relations & Corp. Communications
  • Ms. Catherine Jhung, Sr. Managing Director of Bus. Devel.
  • Ms. Stephanie Lau-Chen, VP of HR
  • Mr. R. Bryan Jadot, Sr. MD & Group Head of Life Sciences (Age 57)
  • Mr. Michael Bowden, Managing Director of Portfolio Management

What is Scott Bluestein's approval rating as Hercules Capital's CEO?

3 employees have rated Hercules Capital CEO Scott Bluestein on Glassdoor.com. Scott Bluestein has an approval rating of 71% among Hercules Capital's employees.

Who are some of Hercules Capital's key competitors?

What other stocks do shareholders of Hercules Capital own?

What is Hercules Capital's stock symbol?

Hercules Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "HTGC."

Who are Hercules Capital's major shareholders?

Hercules Capital's stock is owned by many different institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (2.08%), Sound Income Strategies LLC (1.80%), Royal Bank of Canada (1.73%), Granite Investment Partners LLC (1.02%), Van ECK Associates Corp (1.01%) and Advisors Capital Management LLC (0.92%). Company insiders that own Hercules Capital stock include Carol L Foster, Gayle A Crowell, Scott Bluestein and Thomas J Fallon.
View institutional ownership trends for Hercules Capital
.

Which institutional investors are selling Hercules Capital stock?

HTGC stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., BlackRock Inc., Royal Bank of Canada, Standard Life Aberdeen plc, Barclays PLC, Granite Investment Partners LLC, Guggenheim Capital LLC, and Rockefeller Capital Management L.P.. Company insiders that have sold Hercules Capital company stock in the last year include Scott Bluestein, and Thomas J Fallon.
View insider buying and selling activity for Hercules Capital
or view top insider-selling stocks.

Which institutional investors are buying Hercules Capital stock?

HTGC stock was purchased by a variety of institutional investors in the last quarter, including UBS Group AG, Hennion & Walsh Asset Management Inc., Van ECK Associates Corp, CIBC Private Wealth Group LLC, International Assets Investment Management LLC, FIL Ltd, Assenagon Asset Management S.A., and Alliancebernstein L.P.. Company insiders that have bought Hercules Capital stock in the last two years include Carol L Foster, and Gayle A Crowell.
View insider buying and selling activity for Hercules Capital
or or view top insider-buying stocks.

How do I buy shares of Hercules Capital?

Shares of HTGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hercules Capital's stock price today?

One share of HTGC stock can currently be purchased for approximately $17.18.

How much money does Hercules Capital make?

Hercules Capital has a market capitalization of $1.99 billion and generates $267.87 million in revenue each year. The financial services provider earns $173.60 million in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does Hercules Capital have?

Hercules Capital employs 82 workers across the globe.

When was Hercules Capital founded?

Hercules Capital was founded in 2003.

What is Hercules Capital's official website?

The official website for Hercules Capital is www.htgc.com.

Where are Hercules Capital's headquarters?

Hercules Capital is headquartered at 400 HAMILTON AVE SUITE 310, PALO ALTO CA, 94301.

How can I contact Hercules Capital?

Hercules Capital's mailing address is 400 HAMILTON AVE SUITE 310, PALO ALTO CA, 94301. The financial services provider can be reached via phone at 650-289-3060 or via email at [email protected]


This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.